期刊文献+

利维爱(Livial)对动脉粥样硬化兔组织内雌激素受体和低密度脂蛋白受体的影响 被引量:1

The Effect of Livial on Estrogen Receptor and Low-density Lipoprotein Receptor in Tissues of Atherosclerotic Rabbit
下载PDF
导出
摘要 以去势雌兔作为对照,用高胆固醇饮食法复制动脉粥样硬化(AS)模型,研究了利维爱(Livial)在防治兔动脉粥样硬化过程中对雌激素受体和低密度脂蛋白受体mRNA表达的影响。应用RT-PCR方法,β-actin做内参照,对各组去势雌兔心脏、肝脏组织内雌激素受体和低密度脂蛋白受体mRNA的表达进行了检测。结果,2种受体在兔心脏和肝脏内均有表达。对照组,雌激素受体在心脏、肝脏内的相对表达量分别为0.43±0.12、0.39±0.20;低密底脂蛋白受体在心脏、肝脏内的相对表达量分别为0.27±0.05、0.86±0.12,差异显著(P<0.001)。AS模型组,雌激素受体和低密度脂蛋白受体在心脏、肝脏内的相对表达量分别为0.29±0.03、0.27±0.06和0.04±0.01、0.17±0.02,2种受体的mRNA表达均比对照组降低,差异显著(P<0.001)。利维爱组(饲喂高胆固醇饲料同时给予利维爱),雌激素受体在心脏、肝脏内的相对表达量为0.41±0.09、0.36±0.06,与模型组相比表达量显著提高(P<0.001),与对照组表达量接近;低密度脂蛋白受体在心脏、肝脏内的相对表达量为0.04±0.02、0.18±0.04,与模型组比较未见显著变化。由此认为,组织内2种受体的mRNA表达量降低可促进动脉粥样硬化的发生;利维爱通过提高组织内雌激素受体mRNA的表达可防治AS的发生与发展,对低密度脂蛋白受体的mRNA表达影响较小。 To study the effect of Livial on ER and LDLR of atherosclerotic rabbits.Methord:Rabbits oophorectomized and fed with normal feedstaff were used as control group.An atherosclerosis animal model was created with high cholesterol feed.We studied the effect of livial on the expression of estrogen receptor and low-density lipoprotein receptor mRNA in heart and liver with half quantity RT-PCR.Results:The two receptors expressed in heart and liver;the ER mRNA expression in the heart and liver of control were 0.43±0.12,0.39±0.20,the low-density lipoprotein receptor mRNA expression in the heart and liver were 0.27±0.05,0.86±0.12;The estrogen receptor and low-density lipoprotein receptor mRNA expression in the heart and liver of model separately were 0.29±0.03,0.27±0.06 and 0.04±0.01,0.17±0.02.The mRNA expession of the two receptors reduced than that of the control group.In the livial group,the expession of ER in the heart and liver were 0.41±0.09,0.36±0.06 and significantly increased as compared with the model group(P<0.001).The expession of LDLR in the heart and liver were 0.04±0.02,0.18±0.04.Conclusion:The reduce of the two receptors could accelerate the developoment of AS;Livial could protect against the occuration and development of AS by increasing the mRNA expression of ER.
出处 《中国兽医学报》 CAS CSCD 北大核心 2005年第4期417-419,共3页 Chinese Journal of Veterinary Science
关键词 雌激素受体 低密度脂蛋白受体 RT-PCR 动脉粥样硬化 利维爱 estrogen receptor low-density lipoprotein receptor rabbit RT-PCR atherosclerosis Livial
  • 相关文献

参考文献11

  • 1崔亚利,赵德明,于书敏.利维爱(Livial)对去势雌兔动脉粥样硬化影响的病理学观察[J].中国兽医学报,2005,25(1):60-62. 被引量:3
  • 2曹廷兵,叶治家,巩燕,彭家和.一种快速鉴定RNA质量的方法[J].第三军医大学学报,2002,24(8):992-993. 被引量:27
  • 3刘萍,张静生.冠心康对高脂血症大鼠肝脏低密度脂蛋白受体活性的影响[J].中国动脉硬化杂志,2003,11(2):159-160. 被引量:19
  • 4Ingrid B Meeuwsen,Monique M Samson,Sijmen A Duursma,etal. The influence of tibolone on quality of life in postmenopausal women[J]. Maturitas,2002,41 :35-43.
  • 5Egarter C,Sator M,Berghammer P,et al. Efficacy,tolerability,and rare side effect of tibolone treatment in postmenopausal women[J]. Int J Gynecol Obstet, 1999,64:281-286.
  • 6黄德芳,高玉芬,吴志兰.Raloxifene与利维爱对去卵巢大鼠血脂的影响[J].中国航天工业医药,2001,3(2):26-28. 被引量:4
  • 7Cooper A D,Nutik R,Chen J. Characterization of the estrogeninduced lipoprotein receptorof rat liver[J]. J Lipid Res, 1987.28:59-68.
  • 8Emmison N,Zammit V A,Agius L. Estradiol increases the secretion of hepatic lipase by rat hepatocyte cultures[J]. Biochim Biophys Acta,1991,1 083:147-152.
  • 9Paola Albertazzi,Raffaele Di Micco,Ettore Zanardi. Tibolone:a review[J]. Maturitas, 1998,30:295-305.
  • 10Michael E Carley,David J Rickard,John B Gebhart,et al. Distribution of estrogen receptor α and β mRNA in mouse urogenital tissue and their expression after oophorectomy and estro gen replacement[J]. Int Urogynecol J, 2003,14:141-145.

二级参考文献23

  • 1洪瑛,刘秉文,傅明德.人淋巴细胞低密度脂蛋白受体酶联测定法的研究[J].生物化学与生物物理进展,1993,20(4):297-300. 被引量:4
  • 2姜传仓,蔡海江,范乐明,李传富,王南,陈秀英.丹参对LDL受体及apoA-Ⅰ mRNA水平的影响[J].南京医科大学学报(自然科学版),1994,14(4):522-525. 被引量:43
  • 3J.萨姆布鲁克 E.F.弗里奇.分子克隆实验指南(第2版)[M].北京:科学出版社,1992.830-893.
  • 4[1]孙瑞元编.定量药理学.第1版.北京:人民卫生出版社,1985,247.
  • 5[2]Castelo-Branco C, Vicente JJ, Figueras F. et al. Comparativeeffects of estrogens plus androgens and tibolone on bone, lipidpattern and sexuality in postmenopausal women. M aturitas2000,34(2): 161-8.
  • 6[3]Bruce Ettinger, Dennis M. Black, Bruce H. Mitlak, et al.Reduction of Vertebral Fracture Risk in PostmenopausalWomen With Osteoporosis Treated With Raloxifene. JAMA,1999.282: 637-645.
  • 7[4]Steven R. Cummings, Stephen Eckert, Kathryn A. Krueger,et al. The Effect of Raloxifene on Risk Of Breast Cancer inPostmenopausal Women. JAM A, 1999,281:2189-2197.
  • 8[5]Pierre D, Delmas. Effects of Raloxifene on Bone Mineral Den-sity, Serum Cholesterol Concentrations and Uterine Endom-etrium in Postmenopausal Women. New England Journal ofMedicine, 1997, 337:1641-1647.
  • 9[6]Eaker E, Chesebro JH, Sacks FM , et al. Cardiovascular dis-ease in women. Circulation, 1993,88:1999-2009.
  • 10[7]Stephen Hulley, MD; Deborah Grady, MD; Trudy Bush, etal. Randomized Trial of Estrogen Plus Progestin for Second-ary Prevention of Coronary Heart Disease in PostmenopausalWomen .JAM A. 1998,208:605-613.

共引文献79

同被引文献10

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部